Company Filing History:
Years Active: 2013
Title: Ana Belen Garcia Garcia: Innovator in Cancer Treatment
Introduction
Ana Belen Garcia Garcia is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer research through her innovative work on protein kinase inhibitors. Her dedication to advancing medical science has led to the development of valuable compounds that hold promise for cancer treatment.
Latest Patents
Ana Belen Garcia Garcia holds a patent for "Imidazolothiadiazoles for use as protein kinase inhibitors." This patent includes compounds of formula (I), wherein Z, M, R, X, R, and B have specific meanings as described in the patent. These compounds are particularly useful in treating diseases where the inhibition of a protein kinase, such as a PIM family kinase or PI3-K, is desired or required. This innovation is especially relevant in the fight against cancer.
Career Highlights
Ana Belen Garcia Garcia is affiliated with the Centro Nacional de Investigaciones Oncológicas (CNIO), where she conducts her research. Her work has been instrumental in exploring new therapeutic avenues for cancer treatment. With a focus on developing effective inhibitors, she has positioned herself as a key figure in the oncology research community.
Collaborations
Ana collaborates with esteemed colleagues, including Paolo Pevarello and Ana Maria Garcia Collazo. These partnerships enhance her research efforts and contribute to the advancement of cancer therapies.
Conclusion
Ana Belen Garcia Garcia's innovative work in developing protein kinase inhibitors showcases her commitment to improving cancer treatment. Her contributions to the field are invaluable and highlight the importance of research in combating this disease.